Recent Posts

BIOREM Reports Second Quarter 2021 Financial Results

GUELPH, ON, July 28, 2021 /CNW/ – BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced its results for the three and six-month periods ended June 30, 2021. Biorem’s complete second quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com). FINANCIAL HIGHLIGHTS:   in CDN$’000 except per ...

BIOREM Reports First Quarter 2021 Financial Results

GUELPH, ON, May 19, 2021 /CNW/ – BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced results for the three month period ended March 31, 2021.  Biorem’s complete 2021 first quarter financial statements and MD&A have been filed on SEDAR (www.sedar.com). Financial Summary:     Three-months ended   March 31 December 31 ( in ...

Biorem Reports $2.1 million Earnings for Fiscal 2020

GUELPH, ON, March 31, 2021 /CNW/ – BIOREM Inc. (TSXV: BRM) (“Biorem” or “the Company”) today announced its results for the three and twelve-month periods ended December 31, 2020. Biorem’s complete fiscal 2020 year-end financial statements and MD&A have been filed on SEDAR (www.sedar.com). FINANCIAL HIGHLIGHTS: in ‘000’s except earnings per share   Three-months ...

Investor Resources Contact Form

Financial Statements

YearQuarterTypeDocument
2021Quarter 2Statement2021-Q2
2021Quarter 2MD&A2021-Q2-MDA
2021Quarter 1Statement2021-Q1
2021Quarter 1MD&A2021-Q1-MDA
2020Quarter 4/YearlyStatement2020-Q4
2020Quarter 4/YearlyMD&A2020-Q4-MDA
2020Quarter 3Statement2020-Q3
2020Quarter 3MD&A2020-Q3-MDA
2020Quarter 2Statement2020-Q2
2020Quarter 2MD&A2020-Q2-MDA
2020Quarter 1Statement2020-Q1
2020Quarter 1MD&A2020-Q1-MDA
2019Quarter 4/YearlyStatement2019-Q4
2019Quarter 4/YearlyMD&A2019-Q4-MDA
2019Quarter 3Statement2019-Q3
2019Quarter 3MD&A2019-Q3-MDA
2019Quarter 2Statement2019-Q2
2019Quarter 2MD&A2019-Q2-MDA
2019Quarter 1Statement2019-Q1
2019Quarter 1MD&A2019-Q1-MDA
2018Quarter 4/YearlyStatement2018-Q4
2018Quarter 4/YearlyMD&A2018-Q4-MDA
2018Quarter 3Statement2018-Q3
2018Quarter 3MD&A2018-Q3-MDA
2018Quarter 2Statement2018-Q2
2018Quarter 2MD&A2018-Q2-MDA
2018Quarter 1Statement2018-Q1
2018Quarter 1MD&A2018-Q1-MDA
2017Quarter 4/YearlyStatement2017-Q4
2017Quarter 4/YearlyMD&A2017-Q4-MDA
2017Quarter 3Statement2017-Q3
2017Quarter 3MD&A2017-Q3-MDA
2017Quarter 2Statement2017-Q1
2017Quarter 2MD&A2017-Q2-MDA
2017Quarter 1Statement2017-Q1
2017Quarter 1MD&A2017-Q1-MDA
2016Quarter 4/YearlyStatement2016-Q4
2016Quarter 4/YearlyMD&A2016-Q4-MDA
2015Quarter 4/YearlyStatement2015-Q4
2015Quarter 4/YearlyMD&A2015-Q4-MDA
2014Quarter 4/YearlyStatement2014-Q4
2014Quarter 4/YearlyMD&A2014-Q4-MDA
2013Quarter 4/YearlyStatement2013-Q4
2013Quarter 4/YearlyMD&A2013-Q4-MDA
2012Quarter 4/YearlyStatement2012-Q4
2012Quarter 4/YearlyMD&A2012-Q4-MDA
2011Quarter 4/YearlyStatement2011-Q4
2011Quarter 4/YearlyMD&A2011-Q4-MDA
2010Quarter 4/YearlyStatement2010-Q4
2010Quarter 4/YearlyMD&A2010-Q4-MDA
2009Quarter 4/YearlyStatement2009-Q4
2009Quarter 4/YearlyMD&A2009-Q4-MDA
2008Quarter 4/YearlyStatement2008-Q4
2008Quarter 4/YearlyMD&A2008-Q4-MDA
2007Quarter 4/YearlyStatement2007-Q4
2006Quarter 4/YearlyMD&A2007-Q4-MDA